Patients with differentiated thyroid carcinoma (DTC) are treated with 131I therapy after total
thyroidectomy or surgical resection of recurrent tumor. However, some recurrent DTC …

Background: 18F-FDG-PET/CT applications in the field of differentiated thyroid cancer (DTC)
are continuously growing. Objective: To retrospectively analyze in a wide population …

PET using 18F-FDG has been shown to effectively detect various types of cancer by their
increased glucose metabolism. The aim of this study was to evaluate the use of coregistered …

Aim. Stage-IV differentiated thyroid cancer (DTC) patients may present elevated serum
thyroglobulin (Tg) levels associated with positive [131I] whole-body-scan (WBS) …

Abstract Aims 18 F-FDG PET/CT is the most accurate imaging modality in differentiated
thyroid cancer (DTC) patients with either an aggressive histology, an absence of radioiodine …

Purpose Advanced tumour stage and initial metastases are associated with reduced general
and tumour-free survival in patients with differentiated thyroid carcinoma. Optimal initial …

Background Exact localization of recurrent iodine-negative thyroid cancer is mandatory,
since surgery is the only curative therapy option in patients with iodine-negative tumor …

The therapeutic approach to recurrent well-differentiated thyroid cancer is based on the
detection of active disease. While a measured increase of thyroglobulin level in an ablated …

In a previous paper, we published the impact of initial [18 F] FDG PET/CT (FDG-PET/CT) in
high-risk patients with differentiated thyroid cancer (DTC) and described the changes in …

Purpose: There are approximately 32,000 new cases of thyroid carcinoma annually in the
United States. F-18 FDG PET/CT has an established role in cancer management, including …